Gene · 6334
Papers2,325
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,325
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Differential effects of sodium channel blockers on SCN8A gain-of-function variants associated with drug-responsive or -resistant epilepsy. | Pharmacol Res | 2026 | 42800573 | PubTator, text mining | PubMed |
| Experimental induction of myelin damage in post-mortem human brain slice cultures. | Acta Neuropathol Commun | 2026 | 42760561 | PubTator, text mining | PubMed |
| A designer saxitoxin-engineered sodium channel pair as a general tool for subtype-selective inhibition. | Cell Chem Biol | 2026 | 42679814 | PubTator, text mining | PubMed |
| [Electroclinical recognition of SCN2A, SCN8A, KCNQ2, and KCNQ3 pathogenic variants]. | Medicina (B Aires) | 2026 | 42659555 | PubTator, text mining | PubMed |
| Antiseizure Medications in Development: Novel Mechanisms, Precision Therapy, and the Move Towards Disease Modification. | Curr Issues Mol Biol | 2026 | 42651828 | PubTator, text mining | PubMed |
| Molecular determinants of functional voltage-gated sodium (Nav) channel diversity in mammalian central neurons. | J Physiol | 2026 | 42555659 | PubTator, text mining | PubMed |
| Sodium ion channels as therapeutic targets in epilepsy: a drug discovery perspective. | Bioorg Chem | 2026 | 42508198 | PubTator, text mining | PubMed |
| Progress report on new epilepsy treatments: A summary of the Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVIII). II. Treatments in more advanced clinical development. | Epilepsia | 2026 | 42470359 | PubTator, text mining | PubMed |
| Functional evidence for SCN8A splice-donor variant c.4419+1 A > G causing loss of function. | Hum Genome Var | 2026 | 42373593 | PubTator, text mining | PubMed |
| Differential regulation of β1-dependent voltage shifts and kinetic modulation by an extracellular glutamate in NaV1.6 VSDIV. | J Gen Physiol | 2026 | 42370886 | PubTator, text mining | PubMed |
| The Bright Side of the Spectrum: Self-Limited Infantile Epilepsy-Related SCN8A Gof Variant. | Int J Dev Neurosci | 2026 | 42357809 | PubTator, text mining | PubMed |
| The genotypic spectrum of complex febrile seizures: insights from high-risk population genetic screening in a pediatric cohort. | Front Neurosci | 2026 | 42325954 | PubTator, text mining | PubMed |
| Editing Out Seizures? Base Editing Shows Promise for SCN8A DEE. | Epilepsy Curr | 2026 | 42317572 | PubTator, text mining | PubMed |
| Diverse binding poses of agonistic neurotoxins on human Nav1.6. | Nature | 2026 | 42271061 | PubTator, text mining | PubMed |
| At the forefront of gene-based therapies in Dravet syndrome. | Expert Opin Emerg Drugs | 2026 | 42268240 | PubTator, text mining | PubMed |
| ACMG/AMP variant classification specifications from the ClinGen Epilepsy Sodium Channel Variant Curation Expert Panel. | Genet Med | 2026 | 42227234 | PubTator, text mining | PubMed |
| Neurophysiological characterization and targeted treatment of rhythmic cortical myoclonus in an SCN8A gain-of-function variant. | Clin Neurophysiol | 2026 | 42214118 | PubTator, text mining | PubMed |
| Development of an Automated Cell-Based Assay for the Detection of the Functional Activity of Saxitoxin. | Toxins (Basel) | 2026 | 42188608 | PubTator, text mining | PubMed |
| Expanding the phenotypic spectrum of FGF12-epilepsy-does prompt precision therapy affect outcomes? | NPJ Genom Med | 2026 | 42185328 | PubTator, text mining | PubMed |
| Implication of genetic-dependent stage in the development of SCN8A-associated epilepsy: a case report. | Front Hum Neurosci | 2026 | 42179731 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6334/papers